Pharmacy
Clear All
Results
Showing of
Shrinking a Safe Harbor to Fit a Consumer Protection Class
Two Days, Two Hearings: NIH and FDA Nominees Go Before the HELP Committee
Holland & Knight Health Dose: March 4, 2025
Holland & Knight Health Dose: February 25, 2025
DEA, HHS Extend Telemedicine Flexibilities for Controlled Substance Prescriptions Through 2025
Massachusetts to Begin Licensing Nonresident Pharmacies and In-State Compounding Pharmacies
Plaintiffs Fail to Backdoor Expansive Early Discovery in GLP-1 MDL
Holland & Knight Health Dose: Pre-Election Outlook
Holland & Knight Health Dose: September 24, 2024
Massachusetts Board of Pharmacy to Take a Big Step: Licensing Nonresident Pharmacies
Massachusetts Board of Pharmacy to Take a Big Step: Licensing Nonresident Pharmacies
Holland & Knight Health Dose: July 23, 2024
Supreme Court's Decision in Diaz Could Be a Boon for Criminal Healthcare Fraud Defendants
Holland & Knight Health Dose: June 18, 2024
Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers
Supreme Court Abortion Pill Ruling Doesn't Challenge FDA's Authority
Holland & Knight Health Dose: May 21, 2024
Holland & Knight Health Dose: April 24, 2024
Holland & Knight Health Dose: April 9, 2024
Value-Based Care Capabilities
Page 1 of 2
